CytoSorbents Corp (NAS:CTSO)
$ 0.8 0.0092 (1.16%) Market Cap: 43.45 Mil Enterprise Value: 52.45 Mil PE Ratio: 0 PB Ratio: 2.29 GF Score: 56/100

Cytosorbents Corp Webinar on CytoSorb Therapy in COVID-19 Patients Transcript

Sep 16, 2021 / 03:00PM GMT
Release Date Price: $8.35 (+1.83%)
Stefan Baudis

Yes, hello, everybody, and a warm welcome here from our studio in Berlin. We just heard music from the Hamburg group, Roman Schuler. They have a little journey through the Harbor of Hamburg. But now we are here in Berlin and -- at the CytoSorbents' studio. And I want to welcome you all to our next International CytoSorbents Experts' Meeting, dealing with a topic, COVID-19. Yes.

And I have the big, big pleasure to welcome a very renowned speakers and excellent experts. The first one is our chairman of today's event. This is Professor Manu Shankar-Hari from London. He is from the Department of Intensive Care Medicine in Guy's and St Thomas' Hospital and School of Immunology, King's College London. Hello, Manu.

Manu Shankar;Hari

Stefan, thank you so much. What a lovely meeting and a start to the meeting. Thank you. It's fantastic music. Thank you very much.

Stefan Baudis

Yes. Thank you to have you here on board. And another thanks goes out to Chicago in the U.S. That's Professor Tae Song. He is a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot